EP3220909
BÚPRÓPÍÓN TIL AÐ STILLA PLASMAÞÉTTNI LYFSINS DEXTRÓMETORFAN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.5.2015EP published:
2.9.2020EP application number:
15861189.7
EP translation filed:
25.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
30.4.2035Expiry date:
30.4.2026Next due date:
30.5.2026
Title:
BUPROPION FOR MODULATING DRUG PLASMA LEVELS OF DEXTROMETORPHAN
Timeline
Today
1.5.2015EP application
2.9.2020EP Publication
25.11.2020Translation submitted
15.12.2020Registration published
30.4.2026Expires
Owner
Name:
Antecip Bioventures II LLCAddress:
630 Fifth Avenue, Suite 2000, New York, NY 10111, US
Inventor
Name:
TABUTEAU, HerriotAddress:
New York, NY 10111, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201414550618Date:
21.11.2014Country:
US
Number:
201414554988Date:
26.11.2014Country:
US
Number:
201414554947Date:
26.11.2014Country:
US
Number:
201414555085Date:
26.11.2014Country:
US
Number:
201514602177Date:
21.1.2015Country:
US
Number:
201514604397Date:
23.1.2015Country:
US
Number:
201514617624Date:
9.2.2015Country:
US
Number:
201514628062Date:
20.2.2015Country:
US
Classification
Categories:
A61K 31/485, A61K 31/137, A61P 25/24, A61P 25/28, A61P 25/02
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.4.2021
Expires: 30.4.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 19.4.2022
Expires: 30.4.2023
Payer: Patice ehf.
Number: 9
Paid: 22.4.2023
Expires: 30.4.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 19.4.2024
Expires: 30.4.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 27.5.2025
Expires: 30.4.2026
Payer: Árnason Faktor ehf.